XML 57 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Compensation/Equity Awards and Purchase Plans (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Stock Options Activity
The following table summarizes stock option activity:
SharesWeighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Term (in years)
Aggregate
Intrinsic
Value
(in millions)
Outstanding, January 1, 202489,760 $410.50   
Granted50,907 $343.76   
Exercised(8,500)$277.77   
Forfeited(30,925)$463.19   
Outstanding, December 31, 2024101,242 $371.99 6.06$2.0 
    
Unvested, December 31, 202438,692 $367.21 9.06$— 
Exercisable, December 31, 202462,550 $374.95 4.21$2.0 
Stock Options Valuation Assumptions
No stock options were granted during the years ended December 31, 2023 and 2022. The weighted-average fair value of stock options granted was estimated using a Black-Scholes option-pricing model with the following weighted-average assumptions for the year ended December 31, 2024:

 Year Ended December 31,
 2024
Expected volatility32.5%
Risk-free interest rate4.07%
Expected life (in years)6.3
Expected dividend
Weighted-average fair value of options granted$137.14
Resticted Stock Activity
The following tables summarize restricted stock units activity:

Restricted Stock
Units
Weighted-
Average
Grant-Date
Fair Value
Weighted-Average
Remaining
Contractual Term
(in years)
Aggregate
Intrinsic Value
(in millions)
Outstanding, January 1, 2024344,593 $460.22   
Granted247,367 $328.56   
Vested(119,848)$475.00   
Forfeited(43,690)$448.94   
Outstanding, December 31, 2024428,422 $381.21 1.87$140.7 
Employee Stock Purchase Plan, Valuation Assumptions
The fair value of the employees’ purchase rights under the 2011 ESPP was estimated using a Black-Scholes model with the following weighted-average assumptions:
 Year Ended December 31,
 202420232022
Expected volatility32.4 %35.4 %41.3 %
Risk-free interest rate5.29 %5.15 %1.71 %
Expected life (in years)0.250.240.25
Expected dividend— — — 
Weighted-average fair value   
of purchase rights$68.78 $90.11 $124.26 
Share-based Payment Arrangement, Expensed and Capitalized, Amount Share-based compensation expense is allocated in the consolidated statements of income (loss) as follows (in millions):
Year ended December 31,
202420232022
Cost of goods sold$6.5 $6.1 $5.4 
Selling, general and administrative expense42.9 43.9 45.6 
Research and development expense12.9 11.3 9.9 
   Share-based compensation expense$62.3 $61.3 $60.9